Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Total Current Liabilities (2016 - 2025)

Adma Biologics (ADMA) has disclosed Total Current Liabilities for 14 consecutive years, with $69.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 25.2% year-over-year to $69.5 million, compared with a TTM value of $69.5 million through Dec 2025, up 25.2%, and an annual FY2025 reading of $69.5 million, up 25.2% over the prior year.
  • Total Current Liabilities was $69.5 million for Q4 2025 at Adma Biologics, up from $56.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $74.9 million in Q2 2025 and bottomed at $18.2 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $43.4 million, with a median of $43.1 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities surged 96.3% in 2021, then fell 5.85% in 2023.
  • Year by year, Total Current Liabilities stood at $30.4 million in 2021, then grew by 29.26% to $39.3 million in 2022, then grew by 26.84% to $49.8 million in 2023, then rose by 11.52% to $55.5 million in 2024, then increased by 25.2% to $69.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for ADMA at $69.5 million in Q4 2025, $56.5 million in Q3 2025, and $74.9 million in Q2 2025.